- Lobbying
- Lobbying by DEA Scheduling Coalition (Informal Coalition)
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Ryan Long | Prof. Stf, Csel, & Chief Csel H E&C Cmte LC Rep Norwood; LA& LD Rep Barton See prior filing |
Dave Boyer | Sp Ast Pres LA, Ast Com Leg, FDA;Con Asst, Off of Sec Lab Sp Ast Sec HHS, Con Asst, Off of WH Liaison DoD |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Q2 Report
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Provide guidance and strategic counsel on federal regulatory policy regarding DEA's scheduling of FDA approved pharmaceutical products..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate